{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:51:02Z","timestamp":1765374662269,"version":"3.46.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      To explore whether alterations in regional cerebral perfusion observed on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET imaging could predict \u03b2-amyloid positivity in patients with Lewy body disease (LBD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We enrolled 132 patients with LBD (78 dementia with Lewy bodies and 54 Parkinson disease) who underwent dual-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET and\n                      <jats:sup>18<\/jats:sup>\n                      F-FBB PET scans at initial assessment. Patients were divided into the amyloid-positive (n=69) and amyloid-negative (n=63) groups. We compared regional uptake on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET images between the 2 groups, whereas a linear discriminant analysis (LDA) was performed to predict \u03b2-amyloid positivity based on the standard uptake value ratios (SUVRs) of each region of interest. Mediation analyses were performed to evaluate whether regional cerebral perfusion mediated the association between \u03b2-amyloid load and longitudinal changes in the Mini-Mental State Examination (MMSE) scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were no significant differences in age, sex, educational attainment, MMSE scores, motor deficits, or striatal dopamine depletion between the amyloid-positive and amyloid-negative groups. The amyloid-positive group exhibited decreased uptake in the parietal, precuneus, middle\/inferior temporal, and isthmus cingulate cortices, as well as increased uptake in the caudate, compared with the amyloid-negative group on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET images. LDA prediction model demonstrated that SUVRs of the inferior parietal cortex and caudate optimally distinguished the 2 groups. Greater \u03b2-amyloid burden was associated with a more rapid decline in MMSE scores, which was partially mediated by inferior parietal hypoperfusion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Alterations in regional cerebral perfusion on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET imaging may serve as a useful biomarker for predicting \u03b2-amyloid deposition in LBD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006203","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T19:01:13Z","timestamp":1765220473000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of Amyloid Positivity in Lewy Body Disease Using Early-Phase 18F-FP-CIT PET Images"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-3199","authenticated-orcid":false,"given":"Seok Jong","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul"},{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-3524","authenticated-orcid":false,"given":"Su Hong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiology, Yeungnam University College of Medicine, Daegu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-4390","authenticated-orcid":false,"given":"Seong Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul"},{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-6948","authenticated-orcid":false,"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-1552","authenticated-orcid":false,"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul"},{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5907-3787","authenticated-orcid":false,"given":"Yong","family":"Jeong","sequence":"additional","affiliation":[{"name":"Program of Brain and Cognitive Engineering"},{"name":"Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-8462","authenticated-orcid":false,"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul"},{"name":"Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"R2-20251210","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy body disease or diseases with Lewy bodies?","volume":"8","author":"Men\u0161\u00edkov\u00e1","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/jnr.21352","article-title":"Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1","volume":"85","author":"Kurata","year":"2007","journal-title":"J Neurosci Res"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mds.25213","article-title":"\u03b2-Amyloid and postural instability and gait difficulty in Parkinson\u2019s disease at risk for dementia","volume":"28","author":"M\u00fcller","year":"2013","journal-title":"Mov Disord"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"e16364","DOI":"10.1111\/ene.16364","article-title":"Association between striatal amyloid deposition and motor prognosis in Parkinson\u2019s disease","volume":"31","author":"Park","year":"2024","journal-title":"Eur J Neurol"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.24261","article-title":"Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson\u2019s Disease 2014 conference","volume":"76","author":"Sieber","year":"2014","journal-title":"Ann Neurol"},{"key":"R11-20251210","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","article-title":"Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease","volume":"90","author":"Pilotto","year":"2018","journal-title":"Neurology"},{"key":"R12-20251210","doi-asserted-by":"crossref","first-page":"103080","DOI":"10.1016\/j.nicl.2022.103080","article-title":"Metabolic brain pattern in dementia with Lewy bodies: relationship to Alzheimer\u2019s disease topography","volume":"35","author":"Perovnik","year":"2022","journal-title":"Neuroimage Clin"},{"key":"R13-20251210","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1111\/ene.16007","article-title":"Is the cingulate island sign a marker for early dementia conversion in Parkinson\u2019s disease?","volume":"30","author":"Chung","year":"2023","journal-title":"Eur J Neurol"},{"key":"R14-20251210","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2967\/jnumed.120.257345","article-title":"Dynamic (18)F-FPCIT PET: quantification of Parkinson\u2019s disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session","volume":"62","author":"Peng","year":"2021","journal-title":"J Nucl Med"},{"key":"R15-20251210","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.29565","article-title":"Differential implications of cerebral hypoperfusion and hyperperfusion in Parkinson\u2019s disease","volume":"38","author":"Jeong","year":"2023","journal-title":"Mov Disord"},{"key":"R16-20251210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.22381","article-title":"Amnestic mild cognitive impairment in Parkinson\u2019s disease: a brain perfusion SPECT study","volume":"24","author":"Nobili","year":"2009","journal-title":"Mov Disord"},{"key":"R17-20251210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"88","author":"Firbank","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-20251210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-016-0198-6","article-title":"Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"8","author":"Blanc","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"R19-20251210","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"R20-20251210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","article-title":"Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients","volume":"12","author":"Nomura","year":"2011","journal-title":"Sleep Med"},{"key":"R21-20251210","first-page":"300","article-title":"A validity study on the korean mini-mental state examination (K-MMSE) in dementia patients","volume":"15","author":"Kang","year":"1997","journal-title":"J Korean Neurol Assoc"},{"key":"R22-20251210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12779\/dnd.2023.22.1.1","article-title":"The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment","volume":"22","author":"Ryu","year":"2023","journal-title":"Dement Neurocogn Disord"},{"key":"R23-20251210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol"},{"key":"R24-20251210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","article-title":"Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages","volume":"214","author":"Borghammer","year":"2010","journal-title":"Brain Struct Funct"},{"key":"R25-20251210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.26827","article-title":"Hippocampal perfusion affects motor and cognitive functions in Parkinson disease: an early phase (18) F-FP-CIT positron emission tomography study","volume":"95","author":"Chun","year":"2024","journal-title":"Ann Neurol"},{"key":"R26-20251210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","article-title":"PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET\u2014application to amyloid imaging with AV45-PET","volume":"147","author":"Gonzalez-Escamilla","year":"2017","journal-title":"Neuroimage"},{"key":"R27-20251210","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","article-title":"The Alzheimer\u2019s disease neuroimaging initiative 2 PET core: 2015","volume":"11","author":"Jagust","year":"2015","journal-title":"Alzheimer Dement J Alzheimer Assoc"},{"key":"R28-20251210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"R29-20251210","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R30-20251210","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"R31-20251210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"R32-20251210","doi-asserted-by":"crossref","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","article-title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","volume":"95","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"R33-20251210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies","volume":"88","author":"Lemstra","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R34-20251210","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.2967\/jnumed.121.263195","article-title":"The role of amyloid PET in imaging neurodegenerative disorders: a review","volume":"63","author":"Chapleau","year":"2022","journal-title":"J Nucl Med"},{"key":"R35-20251210","doi-asserted-by":"crossref","first-page":"e1344","DOI":"10.1212\/WNL.0000000000009168","article-title":"Clinical and striatal dopamine transporter predictors of \u03b2-amyloid in dementia with Lewy bodies","volume":"94","author":"Yoo","year":"2020","journal-title":"Neurology"},{"key":"R36-20251210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling","year":"2009","journal-title":"Neuron"},{"key":"R37-20251210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"R38-20251210","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1038\/s41598-017-15263-2","article-title":"Cingulate island sign temporally changes in dementia with Lewy bodies","volume":"7","author":"Iizuka","year":"2017","journal-title":"Sci Rep"},{"key":"R39-20251210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/RLU.0000000000005211","article-title":"Hypoperfusion in Alzheimer\u2019s disease-prone regions and dementia conversion in Parkinson\u2019s disease","volume":"49","author":"Chun","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R40-20251210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12149-016-1076-9","article-title":"Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies","volume":"30","author":"Iizuka","year":"2016","journal-title":"Ann Nucl Med"},{"key":"R41-20251210","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"R42-20251210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00002093-199910000-00009","article-title":"Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study","volume":"13","author":"Wolf","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R43-20251210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0304-3940(91)90918-J","article-title":"Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients","volume":"123","author":"Leh\u00e9ricy","year":"1991","journal-title":"Neurosci Lett"},{"key":"R44-20251210","doi-asserted-by":"crossref","first-page":"1035746","DOI":"10.3389\/fnagi.2022.1035746","article-title":"Altered anterior cingulate cortex subregional connectivity associated with cognitions for distinguishing the spectrum of pre-clinical Alzheimer\u2019s disease","volume":"14","author":"Yuan","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R45-20251210","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.27403","article-title":"Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies","volume":"33","author":"Donaghy","year":"2018","journal-title":"Mov Disord"},{"key":"R46-20251210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"R47-20251210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta amyloid deposition is not associated with cognitive impairment in Parkinson\u2019s disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front Neurol"},{"key":"R48-20251210","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jnr.23777","article-title":"Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer\u2019s disease","volume":"95","author":"Daulatzai","year":"2017","journal-title":"J Neurosci Res"},{"key":"R49-20251210","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neurobiolaging.2014.07.043","article-title":"Correlation between decreased CSF \u03b1-synuclein and A\u03b21-42 in Parkinson disease","volume":"36","author":"Buddhala","year":"2015","journal-title":"Neurobiol Aging"},{"key":"R50-20251210","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov Disord"},{"key":"R51-20251210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.14802\/jmd.22012","article-title":"Accuracy of machine learning using the Montreal Cognitive Assessment for the diagnosis of cognitive impairment in Parkinson\u2019s disease","volume":"15","author":"Jeon","year":"2022","journal-title":"J Mov Disord"},{"key":"R52-20251210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13139-024-00840-x","article-title":"Imaging procedure and clinical studies of [(18)F]FP-CIT PET","volume":"58","author":"Sung","year":"2024","journal-title":"Nucl Med Mol Imaging"},{"key":"R53-20251210","doi-asserted-by":"crossref","first-page":"106024","DOI":"10.1016\/j.parkreldis.2024.106024","article-title":"Patterns of regional cerebral hypoperfusion in early Parkinson\u2019s disease: clinical implications","volume":"121","author":"Chung","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"R54-20251210","doi-asserted-by":"crossref","first-page":"110177","DOI":"10.1016\/j.compbiomed.2025.110177","article-title":"Comprehensive evaluation of early-phase FP-CIT PET as a substitute for brain FDG PET in parkinsonism","volume":"192","author":"Son","year":"2025","journal-title":"Comput Biol Med"},{"key":"R55-20251210","doi-asserted-by":"crossref","first-page":"e27019","DOI":"10.1097\/MD.0000000000027019","article-title":"Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders","volume":"100","author":"Chun","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:01:08Z","timestamp":1765371668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006203","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"2025-06-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}